VNB
GSK icon

Virginia National Bank’s GSK GSK Stock Holding History

Virginia National Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,517
Closed -$207K – 51
2019
Q4 		$207K Buy
+3,517
New +$196K 0.18% 83
2019
Q1 		– Sell
-4,766
Closed -$228K – 103
2018
Q4 		$228K Hold
4,766
– – 0.17% 83
2018
Q3 		$240K Buy
+4,766
New +$242K 0.09% 100

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Virginia National Bank's GSK Position: Q1 2020 in Review

Virginia National Bank sold out of GSK (GSK) in Q1 2020, closing a stake of 3,517 shares — an estimated $207K sold.

Virginia National Bank first reported a position in GSK in Q3 2018 and held it in 3 quarters. The position peaked at $240K in Q3 2018. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Virginia National Bank reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Virginia National Bank sold 3,517 GSK shares in Q1 2020, an estimated $207K.
  • Virginia National Bank first reported a position in GSK in Q3 2018 and held it in 3 quarters.
  • Virginia National Bank's GSK position peaked at $240K in Q3 2018.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Virginia National Bank's 13F filing for Q1 2020, filed 17 Apr 2020.